MedTrace Logo

Occipital Transcutaneous Stimulation in Chronic Migraine

NCT02307071 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2015-05-28

No results posted yet for this study

Summary

This study evaluates the effect in chronic migraine patients of daily 20 minute-transcutaneous sub occipital neurostimulation using the occipital Cefaly° device.

Conditions

  • Chronic Migraine

Interventions

DEVICE

Cefaly Kit Arnold

Occipital neurostimulation can have a therapeutic effect in chronic migraine treatment, thus representing a possible therapeutic option in patients that do not respond to any medication.

Sponsors & Collaborators

  • University of Liege

    lead OTHER

Principal Investigators

  • Jean Schoenen, MD, PhD · University of Liege

  • Delphine Magis, MD, PhD · University of Liege

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-09-30
Completion
2015-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02307071 on ClinicalTrials.gov